Scholar, Visiting (EXT)
Center for Life Sciences, 5th Floor
3 Blackfan Circle
Boston MA 02115
Neal Muni, M.D., MSPH, is currently the President of CutisPharma, Inc., a specialty pharmaceutical company focused on the pharmaceutical compounding market. Dr. Muni also currently maintains staff appointments with the Department of Medicine at Brigham and Women's Hospital, where he pratices as an internist with the Brigham Hospitalist Service, and Harvard Medical School, appointed as an Instructor of Medicine.
Prior to joining CutisPharma, Dr. Muni was the Executive Director of New Product Planning at Sunovion Phamaceuticals, the US-based subsidiary of Osaka-based Dainippon Sumitomo Pharma. Prior to joining Sunovion, Dr. Muni was an engagement manager in the strategic advisory practice of Leerink Swann, LLC, a health-care boutique investment bank. Prior to that, Dr. Muni was a Medical Officer in the Division of Cardiovascular Devices at the FDA, serving as the lead medical reviewer for coronary drug eluting stent technologies.
Dr. Muni completed his residency training in internal medicine at the Brigham and Women's Hospital. He received his M.D. as well as Master of Science in Public Health, specializing in biostatistics, from the Tulane School of Medicine, and a B.A. in Business Economics and B.Sc. in Biochemistry from Brown University.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.